Scientists at the University of Georgia have developed a new molecule that may offer fresh hope to people suffering from shingles and herpes.
These conditions affect millions of people around the world and can cause pain, discomfort, and ongoing stress. This new discovery could lead to treatments that are more effective, safer, and easier to use than current options.
The virus behind shingles is called the varicella zoster virus. It is the same virus that causes chickenpox. Many people first get this virus as children in the form of chickenpox. After the illness ends, the virus does not leave the body.
Instead, it stays hidden in the nervous system for many years. Later in life, it can become active again and cause shingles. Shingles often leads to painful skin rashes, burning sensations, and nerve pain that can last for a long time, even after the rash disappears.
Herpes infections are also very common. Herpes simplex virus type 1 usually causes cold sores around the mouth, while type 2 causes genital herpes. These infections can come and go over time, with outbreaks that can be uncomfortable and sometimes difficult to manage.
The new molecule developed by researchers David Chu and Uma Singh is called POM-L-BHDU. Their findings were published in the Journal of Medicinal Chemistry. This molecule has shown strong ability to fight the viruses that cause shingles, chickenpox, and both types of herpes.
Current treatments for these viral infections are not always ideal. Some drugs do not work well for everyone, and others can cause unwanted side effects. In addition, viruses can become resistant to existing medicines over time, making them less effective. This creates a need for new treatments that can work better and more safely.
One of the most promising features of POM-L-BHDU is its flexibility. It can be used in several ways, including as a pill, through an injection, or applied directly to the skin as a cream.
This means it could be adapted for different types of patients and different stages of infection. For example, a cream version could be used at home to treat cold sores or shingles outbreaks quickly and conveniently.
In laboratory tests and studies with mice, the molecule performed better than many existing drugs. When used as a topical cream, it was able to stop the virus from spreading to other parts of the body.
Because the medicine stays mostly on the skin when applied as a cream, less of it enters the bloodstream. This may reduce the risk of side effects, which is an important advantage for patients.
Another exciting finding is that this molecule works against multiple viruses. It targets not only the varicella zoster virus but also herpes simplex virus types 1 and 2. This means it could potentially become a single treatment option for several common viral infections.
The researchers believe that, in the future, the cream version of this medicine could be available without a prescription. This would make it much easier for people to treat outbreaks quickly at home, without needing to visit a doctor each time. Faster treatment could help reduce symptoms and prevent the virus from spreading.
So far, the new molecule has shown positive results in laboratory studies and animal testing. It has also been tested on human skin samples in the lab, where it performed well. The next important step is to conduct clinical trials in humans to confirm that the treatment is safe and effective in real patients.
The University of Georgia Research Foundation has licensed this technology to a company called Anterogen Co., which will help develop the drug further and bring it closer to real-world use. This partnership is an important step in turning scientific discovery into a treatment that can benefit patients.
Overall, this new molecule represents a promising advance in the fight against shingles and herpes. If future studies confirm its safety and effectiveness, it could provide a better way to manage these infections, reduce pain, and improve quality of life for many people around the world.
If you care about cancer, please read studies that artificial sweeteners are linked to higher cancer risk, and how drinking milk affects risks of heart disease and cancer.
For more health information, please see recent studies about the best time to take vitamins to prevent heart disease, and results showing vitamin D supplements strongly reduces cancer death.
Copyright © 2026 Knowridge Science Report. All rights reserved.
